Evidence map›Paper›PMID 20625696›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2010

In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation.

Ketan Marballi, Marlon P Quinones, Fabio Jimenez, Michael A Escamilla, Henriette Raventós, Maria Clara Soto-Bernardini, Seema S Ahuja, Consuelo Walss-Bass

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus.Therapeutic advances in endocrinology and metabolism · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Nrg1 Intracellular Signaling Is Neuroprotective upon Stroke.Oxidative medicine and cellular longevity · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. ERBB signaling attenuates proinflammatory activation of nonclassical monocytes.American journal of physiology. Heart and circulatory physiology · 2017
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ketan MarballiDepartment of Cellular and Structural Biology and Psychiatry, University of Texas Health Sciences Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
Marlon P Quinones
Fabio Jimenez
Michael A Escamilla
Henriette Raventós
Maria Clara Soto-Bernardini
Seema S Ahuja
Consuelo Walss-Bass
The University of Texas Health Science Center at San Antonio · USUniversidad de Costa Rica · CRTexas Tech University · US

Funding

Correlation of Allelic Variations with Gene Function Alterations in SchizophreniaK01MH077777 · NIMH · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI WALSS-BASS, CONSUELO · 2008 to 2012
$745k
NIMH NIH HHS K01 MH077777NIMH NIH HHS K01MH077777
6 · The paper itself

Abstract

Neuregulin 1 (NRG1) has been implicated in several disorders including breast cancer, multiple sclerosis, and schizophrenia. Also, recent evidence suggests that NRG1 may play a role in regulation of inflammation and immune system response. We therefore hypothesized that a schizophrenia-associated missense mutation (valine to leucine) we identified within the transmembrane region of NRG1 would also be linked to immune dysregulation. We used plasma samples from families carrying the mutation to measure levels of antibodies to 41 autoimmune markers and six cytokines (IL-1b, IL-6, IL-10, IL-8, IL-12p70, and TNF-α) and used these levels as quantitative traits to evaluate association with the NRG1 mutation, using FBAT. Next, we used Epstein-Barr virus-transformed B cells from heterozygous mutation carriers and wild-type individuals to evaluate protein and mRNA cytokine expression in vitro using quantitative PCR and ELISA assays. In vivo, increased levels of 25 autoimmune markers as well as elevated levels of cytokines were significantly associated with the NRG1 mutation. In vitro, we observed a significant increase in protein secretion levels of IL-6, TNF-α, and IL-8 in mutation carriers compared with controls. At the mRNA level, we observed a significant increase in IL-6 expression, while IL-4 levels appeared to be down-regulated in heterozygous individuals compared with wild-type controls. This is the first report of association of a NRG1 mutation with immune dysregulation. This study could contribute towards understanding the role of NRG1 in the pathogenesis of schizophrenia and other disorders in which inflammation plays an important role.

Indexed as

AutoantibodiesCell LineCytokinesFemaleGenotypeHumansImmune SystemMaleMutation, MissenseNeuregulin-1PedigreeAutoantibodiesCytokinesNeuregulin-1

Identifiers

PMID20625696
PMCPMC2976656
OpenAlexW2145603619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.